Article info

Download PDFPDF

#124 A phase II, multicentre, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer
Free

Authors

Citation

Ottenbourgs T, Nieuwenhuysen EV
#124 A phase II, multicentre, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer

Publication history

  • First published September 27, 2023.
Online issue publication 
September 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.